vs
Side-by-side financial comparison of Dolby Laboratories, Inc. (DLB) and AMICUS THERAPEUTICS, INC. (FOLD). Click either name above to swap in a different company.
Dolby Laboratories, Inc. is the larger business by last-quarter revenue ($346.7M vs $185.2M, roughly 1.9× AMICUS THERAPEUTICS, INC.). Dolby Laboratories, Inc. runs the higher net margin — 15.4% vs 0.9%, a 14.5% gap on every dollar of revenue. On growth, AMICUS THERAPEUTICS, INC. posted the faster year-over-year revenue change (23.7% vs -2.9%). Dolby Laboratories, Inc. produced more free cash flow last quarter ($50.2M vs $16.0M). Over the past eight quarters, AMICUS THERAPEUTICS, INC.'s revenue compounded faster (29.5% CAGR vs -2.5%).
Dolby Laboratories, Inc. is an American technology corporation specializing in audio noise reduction, audio encoding/compression, spatial audio, and high-dynamic-range television (HDR) imaging. Dolby licenses its technologies to consumer electronics manufacturers.
Amicus Therapeutics, Inc. is a public American biopharmaceutical company based in Philadelphia, Pennsylvania. The company went public in 2007 under the Nasdaq trading symbol FOLD. This followed a 2006 planned offering and subsequent withdrawal, which would have established the trading symbol as AMTX Prior to their IPO, Amicus was funded by a variety of venture capital firms including Radius Ventures, Canaan Partners and New Enterprise Associates.
DLB vs FOLD — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $346.7M | $185.2M |
| Net Profit | $53.3M | $1.7M |
| Gross Margin | 87.5% | 85.7% |
| Operating Margin | 17.9% | 8.6% |
| Net Margin | 15.4% | 0.9% |
| Revenue YoY | -2.9% | 23.7% |
| Net Profit YoY | -21.4% | -88.5% |
| EPS (diluted) | $0.55 | $0.00 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $346.7M | $185.2M | ||
| Q3 25 | $307.0M | $169.1M | ||
| Q2 25 | $315.5M | $154.7M | ||
| Q1 25 | $369.6M | $125.2M | ||
| Q4 24 | $357.0M | $149.7M | ||
| Q3 24 | $304.8M | $141.5M | ||
| Q2 24 | $288.8M | $126.7M | ||
| Q1 24 | $364.5M | $110.4M |
| Q4 25 | $53.3M | $1.7M | ||
| Q3 25 | $49.3M | $17.3M | ||
| Q2 25 | $46.1M | $-24.4M | ||
| Q1 25 | $91.8M | $-21.7M | ||
| Q4 24 | $67.8M | $14.7M | ||
| Q3 24 | $58.6M | $-6.7M | ||
| Q2 24 | $38.4M | $-15.7M | ||
| Q1 24 | $97.8M | $-48.4M |
| Q4 25 | 87.5% | 85.7% | ||
| Q3 25 | 87.1% | 88.5% | ||
| Q2 25 | 86.1% | 90.2% | ||
| Q1 25 | 90.3% | 90.7% | ||
| Q4 24 | 88.6% | 90.1% | ||
| Q3 24 | 88.8% | 90.6% | ||
| Q2 24 | 87.7% | 91.1% | ||
| Q1 24 | 89.4% | 87.7% |
| Q4 25 | 17.9% | 8.6% | ||
| Q3 25 | 9.7% | 20.3% | ||
| Q2 25 | 15.1% | -6.1% | ||
| Q1 25 | 29.2% | -6.3% | ||
| Q4 24 | 22.4% | 10.7% | ||
| Q3 24 | 15.2% | 15.3% | ||
| Q2 24 | 12.7% | 11.8% | ||
| Q1 24 | 29.9% | -25.1% |
| Q4 25 | 15.4% | 0.9% | ||
| Q3 25 | 16.1% | 10.2% | ||
| Q2 25 | 14.6% | -15.8% | ||
| Q1 25 | 24.8% | -17.3% | ||
| Q4 24 | 19.0% | 9.8% | ||
| Q3 24 | 19.2% | -4.8% | ||
| Q2 24 | 13.3% | -12.4% | ||
| Q1 24 | 26.8% | -43.9% |
| Q4 25 | $0.55 | $0.00 | ||
| Q3 25 | $0.50 | $0.06 | ||
| Q2 25 | $0.48 | $-0.08 | ||
| Q1 25 | $0.94 | $-0.07 | ||
| Q4 24 | $0.70 | $0.05 | ||
| Q3 24 | $0.59 | $-0.02 | ||
| Q2 24 | $0.40 | $-0.05 | ||
| Q1 24 | $1.01 | $-0.16 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $644.6M | $293.5M |
| Total DebtLower is stronger | — | $392.7M |
| Stockholders' EquityBook value | $2.6B | $274.2M |
| Total Assets | $3.2B | $949.9M |
| Debt / EquityLower = less leverage | — | 1.43× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $644.6M | $293.5M | ||
| Q3 25 | $702.6M | $263.8M | ||
| Q2 25 | $699.3M | $231.0M | ||
| Q1 25 | $626.6M | $250.6M | ||
| Q4 24 | $520.8M | $249.9M | ||
| Q3 24 | $482.0M | $249.8M | ||
| Q2 24 | $869.0M | $260.1M | ||
| Q1 24 | $825.4M | $239.6M |
| Q4 25 | — | $392.7M | ||
| Q3 25 | — | $392.0M | ||
| Q2 25 | — | $391.3M | ||
| Q1 25 | — | $390.7M | ||
| Q4 24 | — | $390.1M | ||
| Q3 24 | — | $389.5M | ||
| Q2 24 | — | $388.9M | ||
| Q1 24 | — | $388.4M |
| Q4 25 | $2.6B | $274.2M | ||
| Q3 25 | $2.6B | $230.4M | ||
| Q2 25 | $2.6B | $204.3M | ||
| Q1 25 | $2.6B | $193.6M | ||
| Q4 24 | $2.5B | $194.0M | ||
| Q3 24 | $2.5B | $178.8M | ||
| Q2 24 | $2.4B | $132.5M | ||
| Q1 24 | $2.4B | $130.7M |
| Q4 25 | $3.2B | $949.9M | ||
| Q3 25 | $3.2B | $868.8M | ||
| Q2 25 | $3.2B | $815.3M | ||
| Q1 25 | $3.2B | $789.8M | ||
| Q4 24 | $3.2B | $785.0M | ||
| Q3 24 | $3.1B | $786.6M | ||
| Q2 24 | $3.0B | $749.5M | ||
| Q1 24 | $3.0B | $721.8M |
| Q4 25 | — | 1.43× | ||
| Q3 25 | — | 1.70× | ||
| Q2 25 | — | 1.92× | ||
| Q1 25 | — | 2.02× | ||
| Q4 24 | — | 2.01× | ||
| Q3 24 | — | 2.18× | ||
| Q2 24 | — | 2.93× | ||
| Q1 24 | — | 2.97× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $54.8M | $16.3M |
| Free Cash FlowOCF − Capex | $50.2M | $16.0M |
| FCF MarginFCF / Revenue | 14.5% | 8.6% |
| Capex IntensityCapex / Revenue | 1.3% | 0.2% |
| Cash ConversionOCF / Net Profit | 1.03× | 9.62× |
| TTM Free Cash FlowTrailing 4 quarters | $715.3M | $29.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $54.8M | $16.3M | ||
| Q3 25 | $472.2M | $35.7M | ||
| Q2 25 | $67.7M | $-26.5M | ||
| Q1 25 | $174.9M | $7.8M | ||
| Q4 24 | $106.8M | $-3.9M | ||
| Q3 24 | $327.3M | $-23.0M | ||
| Q2 24 | $21.3M | $22.7M | ||
| Q1 24 | $181.4M | $-29.7M |
| Q4 25 | $50.2M | $16.0M | ||
| Q3 25 | $435.9M | $35.3M | ||
| Q2 25 | $61.3M | $-28.9M | ||
| Q1 25 | $168.0M | $7.5M | ||
| Q4 24 | $100.0M | $-4.2M | ||
| Q3 24 | $297.2M | $-23.3M | ||
| Q2 24 | $13.7M | $21.6M | ||
| Q1 24 | $172.5M | $-31.5M |
| Q4 25 | 14.5% | 8.6% | ||
| Q3 25 | 142.0% | 20.9% | ||
| Q2 25 | 19.4% | -18.7% | ||
| Q1 25 | 45.5% | 6.0% | ||
| Q4 24 | 28.0% | -2.8% | ||
| Q3 24 | 97.5% | -16.5% | ||
| Q2 24 | 4.7% | 17.0% | ||
| Q1 24 | 47.3% | -28.5% |
| Q4 25 | 1.3% | 0.2% | ||
| Q3 25 | 11.8% | 0.2% | ||
| Q2 25 | 2.0% | 1.6% | ||
| Q1 25 | 1.9% | 0.2% | ||
| Q4 24 | 1.9% | 0.2% | ||
| Q3 24 | 9.8% | 0.3% | ||
| Q2 24 | 2.6% | 0.9% | ||
| Q1 24 | 2.4% | 1.6% |
| Q4 25 | 1.03× | 9.62× | ||
| Q3 25 | 9.57× | 2.06× | ||
| Q2 25 | 1.47× | — | ||
| Q1 25 | 1.91× | — | ||
| Q4 24 | 1.57× | -0.27× | ||
| Q3 24 | 5.59× | — | ||
| Q2 24 | 0.55× | — | ||
| Q1 24 | 1.85× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
DLB
| Licensing Brodcast Revenue | $100.3M | 29% |
| Licensing Mobile Revenue | $74.9M | 22% |
| Licensing Other Revenue | $70.2M | 20% |
| Licensing CE Revenue | $45.6M | 13% |
| Licensing PC Revenue | $28.7M | 8% |
| Products And Services | $26.9M | 8% |
FOLD
| Other | $105.8M | 57% |
| Galafold | $64.8M | 35% |
| Pombiliti Opfolda | $14.6M | 8% |
